Modifying the physicochemical properties of NSAIDs for nasal and pulmonary administration

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

This review focuses on nasal and pulmonary delivery of NSAIDs (non-steroidal anti-inflammatory drugs) for fast-onset analgesia, for the potential prevention of Alzheimer's disease (AD), as well as for an add-on treatment in cystic fibrosis (CF) and non-small cell lung cancer (NSCLC). I discuss how the physicochemical properties of NSAIDs can be modified with respect to the biological characteristics of the target site. Innovative technology and/or dosage forms can promote an effective therapy.

Original languageEnglish
Pages (from-to)87-93
Number of pages7
JournalDrug Discovery Today: Technologies
Volume27
DOIs
Publication statusPublished - Jul 2018

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'Modifying the physicochemical properties of NSAIDs for nasal and pulmonary administration'. Together they form a unique fingerprint.

  • Cite this